☆ 3.8 Editorial Material

NAFLD in Indians: A Myopic Yet Alarming Perspective

JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Gastroenterology & Hepatology

Incidence and Predictors of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease

Shalimar et al.

Summary: This study aimed to assess the incidence and predictors of liver-related events (LREs) and mortality in nonalcoholic fatty liver disease (NAFLD) patients. The results showed differences in the incidence of LRE and mortality among patients categorized as noncirrhosis (NC), compensated cirrhosis (CC), and decompensated cirrhosis (DC). Diabetes was associated with poor outcomes in NC NAFLD. Age, hypertension, and DC were independent predictors of poor outcomes.

JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort

Tracey G. Simon et al.

Summary: This study demonstrated that patients with biopsy-proven NAFLD have a significantly higher risk of major adverse cardiovascular events, including ischemic heart disease, stroke, congestive heart failure, and cardiovascular mortality, compared to matched population controls. The risk of such events increases progressively with worsening NAFLD severity.

GUT (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Clinical course of non-alcoholic fatty liver disease and the implications for clinical trial design

Alina M. Allen et al.

Summary: The study investigated the risk and progression of NAFLD in a population-based cohort over 23 years, finding that compensated cirrhosis has a certain risk of progression, requiring large sample sizes and long-term follow-up to detect therapeutic effects.

JOURNAL OF HEPATOLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Nonalcoholic Steatohepatitis: Current Thinking From the Division of Hepatology and Nutrition at the Food and Drug Administration

Frank A. Anania et al.

HEPATOLOGY (2021)

添加到收藏夹

Editorial Material Medicine, General & Internal

Nonalcoholic Steatohepatitis - Opportunities and Challenges

Guadalupe Garcia-Tsao

Summary: NASH has become the main cause of cirrhosis and liver transplantation, unlike hepatitis C which is a liver-specific disorder. It is a complex metabolic disorder that requires finding alternative therapies and defining response to treatment, with diagnosis established through liver biopsy samples.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease

Arun J. Sanyal et al.

Summary: In this study involving patients with nonalcoholic fatty liver disease, advanced fibrosis stages F3 and F4 were associated with increased risks of liver-related complications and death over a median of 4 years of follow-up. Advanced fibrosis was also related to an increased incidence of liver decompensation events.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver disease

Jacqueline B. Henson et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)

添加到收藏夹

Review Gastroenterology & Hepatology

Treatment of non-alcoholic fatty liver disease - Current perspectives

Anshuman Elhence et al.

INDIAN JOURNAL OF GASTROENTEROLOGY (2020)

添加到收藏夹

Article Medicine, General & Internal

Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease

David E. Kleiner et al.

JAMA NETWORK OPEN (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

Naga Chalasani et al.

HEPATOLOGY (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study

Eduardo Vilar-Gomez et al.

GASTROENTEROLOGY (2018)

添加到收藏夹

Article Pharmacology & Pharmacy

Natural history of diseases: Statistical designs and issues

Nicholas P. Jewell

CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)

添加到收藏夹

Article Gastroenterology & Hepatology

Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes

Zobair M. Younossi et al.

HEPATOLOGY (2016)

添加到收藏夹

Review Gastroenterology & Hepatology

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

G. Vernon et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)

添加到收藏夹

Article Gastroenterology & Hepatology

The Natural History of Non-Alcoholic Fatty Liver Disease

Stephen Caldwell et al.

DIGESTIVE DISEASES (2010)

添加到收藏夹

Review Gastroenterology & Hepatology

Epidemiology and Natural History of Non-Alcoholic Steatohepatitis

Curtis K. Argo et al.

CLINICS IN LIVER DISEASE (2009)

添加到收藏夹

Article Gastroenterology & Hepatology

Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis

Curtis K. Argo et al.

JOURNAL OF HEPATOLOGY (2009)

添加到收藏夹

Review Gastroenterology & Hepatology

Cryptogenic cirrhosis and NAFLD: Are they related?

A Maheshwari et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.